Ernexa Therapeutics Regains Nasdaq Compliance Over Minimum Bid Price Rule

MT Newswires Live

2025/07/09

Ernexa Therapeutics (ERNA) on Wednesday said it regained compliance with the minimum bid price requirement for continued listing on the Nasdaq Stock Market.

The company said it received formal notice from Nasdaq on July 1 stating that it now meets the minimum bid price requirement.

Shares of Ernexa Therapeutics were up 1.6% in recent trading.

Price: 1.95, Change: +0.03, Percent Change: +1.56

免责声明：投资有风险，本文并非投资建议，以上内容不应被视为任何金融产品的购买或出售要约、建议或邀请，作者或其他用户的任何相关讨论、评论或帖子也不应被视为此类内容。本文仅供一般参考，不考虑您的个人投资目标、财务状况或需求。TTM对信息的准确性和完整性不承担任何责任或保证，投资者应自行研究并在投资前寻求专业建议。

热议股票

{"basename":"/hans","ssrTDKData":{"titleTemplate":"%s - 老虎证券","title":"老虎证券全球投资理财平台| 一站式投资美股新股港股A股","description":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","keywords":"老虎证券,老虎证券开户,老虎券商,老虎证券官网,老虎证券app,tigertrade老虎证券,股票,炒股,新加坡股票交易平台,投资,投资理财","social":{"ogDescription":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/hans/news/2550265618"},"companyName":"老虎证券"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental"},"isCrawlerRequest":true,"__swrFallback__":{"@#url:\"https://stock-news.skytigris.cn/v3/news\",params:#id:\"2550265618\",edition:\"fundamental\",auth_exemption:1,,,undefined,":{"share":"https://ttm.financial/m/news/2550265618?lang=zh_CN&edition=fundamental","thumbnail":"","is_english":true,"pubTime":"2025-07-09 22:42","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"2550265618","market":"nz","top_or_hot":-1,"title":"Ernexa Therapeutics Regains Nasdaq Compliance Over Minimum Bid Price Rule","media":"MT Newswires Live","content":"<html><body><p> Ernexa <a href=\"https://laohu8.com/S/LENZ\">Therapeutics</a> (ERNA) on Wednesday said it regained compliance with the minimum bid price requirement for continued listing on the <a href=\"https://laohu8.com/S/NDAQ\">Nasdaq</a> Stock Market.</p><p>The company said it received formal notice from Nasdaq on July 1 stating that it now meets the minimum bid price requirement.</p><p>Shares of Ernexa Therapeutics were up 1.6% in recent trading.</p><p>Price: 1.95, Change: +0.03, Percent Change: +1.56</p></body></html>","source":"mtnewswires_news","html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Ernexa Therapeutics Regains Nasdaq Compliance Over Minimum Bid Price Rule</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nErnexa Therapeutics Regains Nasdaq Compliance Over Minimum Bid Price Rule\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1092851196\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://community-static.tradeup.com/news/3002d84abbd5ace3c99397c7f95b8d4e);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">MT Newswires Live </p>\n<p class=\"h-time\">2025-07-09 22:42</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<html><body><p> Ernexa <a href=\"https://laohu8.com/S/LENZ\">Therapeutics</a> (ERNA) on Wednesday said it regained compliance with the minimum bid price requirement for continued listing on the <a href=\"https://laohu8.com/S/NDAQ\">Nasdaq</a> Stock Market.</p><p>The company said it received formal notice from Nasdaq on July 1 stating that it now meets the minimum bid price requirement.</p><p>Shares of Ernexa Therapeutics were up 1.6% in recent trading.</p><p>Price: 1.95, Change: +0.03, Percent Change: +1.56</p></body></html>\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"BK4588","symbol_name":"碎股","start_time":0,"source_url":"https://www.mtnewswires.com/","article_id":"2550265618","we_media_id":"1092851196","thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=2550265618","pubTimestamp":1752072152,"columns":[],"sourceInfo":{"source_id":"mtnewswires_news","name":"MT Newswires"},"weMediaInfo":{"media_name":"MT Newswires Live","introduction":"The most recognized names in North America, Europe and Asia rely on MT Newswires to power their applications. Better news, better service, better price.","home_visible":1,"id":"1092851196","head_image":"https://community-static.tradeup.com/news/3002d84abbd5ace3c99397c7f95b8d4e"},"summary":"Ernexa Therapeutics  on Wednesday said it regained compliance with the minimum bid price requirement for continued listing on the Nasdaq Stock Market.The company said it received formal notice from Nasdaq on July 1 stating that it now meets the minimum bid price requirement.Shares of Ernexa Therapeutics were up 1.6% in recent trading.Price: 1.95, Change: +0.03, Percent Change: +1.56","collect":0,"end_time":0,"defaultTopTitle":"","property":[],"viewcount":null,"language":"en","relate_stocks":{"BK4588":"碎股","PSQ":"做空纳斯达克100指数ETF-ProShares","BK4112":"金融交易所和数据","LU2210149790.SGD":"Natixis Thematics Subscription Economy R/A SGD-H","TSYW.SI":"TESLA 3xLongSG261006","BK4007":"制药","SQQQ":"纳指三倍做空ETF","NDAQ":"纳斯达克OMX交易所","LU2210150020.SGD":"Natixis Thematics Subscription Economy R/A SGD","BK4539":"次新股","USJW.SI":"ALPHAB 3xLongSG261006","LU2095319765.USD":"Natixis Thematics Subscription Economy R/A USD","NVIW.SI":"NVDA 3xLongSG261006","TQQQ":"纳指三倍做多ETF","IE00BKPKM429.USD":"NEUBERGER BERMAN GLOBAL SUSTAINABLE EQUITY \"A\" (USD) ACC","BK4585":"ETF&股票定投概念","QLD":"2倍做多纳斯达克100指数ETF-ProShares","BK4139":"生物科技","IE00B64PRP62.GBP":"GUINNESS GLOBAL MONEY MANAGERS \"C\" (GBP) ACC","IE00B3QW5Z07.USD":"GUINNESS GLOBAL MONEY MANAGERS \"C\" (USD) ACC","ERNA":"Eterna Therapeutics Inc.","USAW.SI":"AMZN 3xLongSG261006","QID":"两倍做空纳斯达克指数ETF-ProShares","IE00BGHQF748.EUR":"GUINNESS GLOBAL MONEY MANAGERS \"C\" (EUR) ACC",".IXIC":"NASDAQ Composite","LENZ":"Therapeutics"},"translate_title":"Ernexa Therapeutics重新遵守纳斯达克最低投标价格规则","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"TSYW.SI":0.6,".IXIC":1,"NQmain":1,"USAW.SI":0.6,"SQQQ":0.6,"QID":0.6,"NDAQ":1,"NVIW.SI":0.6,"PSQ":0.6,"ERNA":0.9,"MNQmain":0.6,"TQQQ":0.6,"USJW.SI":0.6,"QLD":0.6,"LENZ":1},"content_text":"Ernexa Therapeutics (ERNA) on Wednesday said it regained compliance with the minimum bid price requirement for continued listing on the Nasdaq Stock Market.The company said it received formal notice from Nasdaq on July 1 stating that it now meets the minimum bid price requirement.Shares of Ernexa Therapeutics were up 1.6% in recent trading.Price: 1.95, Change: +0.03, Percent Change: +1.56","kind":"highlight","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"1","news_tag":"corporation","news_rank":0,"symbols":[],"gpt_button":0,"need_auth":false,"code":"91000000","status":"200"}}}